You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)

✉ Email this page to a colleague

« Back to Dashboard

Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)

Docket	⤷ Sign Up	Date Filed	2014-10-15
Court	District Court, D. Delaware	Date Terminated	2020-12-04
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	ACTAVIS PHARMA INC.; ANDRX CORPORATION
Patents	6,419,960; 7,691,880; 8,062,667; 8,287,903; 8,465,765; 8,563,033; 8,778,390; 8,956,649; 9,040,083
Attorneys	Elizabeth J. Holland; Jennifer Koh
Firms	Barnes and Thornburg LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Tris Pharma Inc. v. Actavis Laboratories FL Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Tris Pharma Inc. v. Actavis Laboratories FL Inc. (D. Del. 2014)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2014-10-15	1		“Notification of Certification for U.S. Patent Nos. 8,062,667; 8,287,903; 8,465,765; 8,563,033 and 8,778,390…States Patent No. 8,465,765 (“the ’765 patent”), United States Patent No. 8,563,033 (“the ’033 patent”), …Actavis has infringed the ’765 patent, the ’033 patent, and the ’390 patent by submitting ANDA 206049 to… to infringement of the ’765 patent, the ’033 patent, and the ’390 patent; -15_ Case 1:14-ov-01309-UNA…after the expiration of the ’765 patent, the ’033 patent, the ’390 patent, or any later expiration of exclusivity	External link to document
2017-09-05	161		1 and Cmax-2)." 153. U.S. Patent No. 6,419,960 ("Krishnamurthy") issued on July…667 Patent, the '903 patent, the '765 patent, the '033 patent, the '390 patent, the…the '649 patent, and the '083 patent (collectively, "the patents-in-suit") are listed… '667 patent is cited on the face of each of the patents-in-suit. The '667 patent expires on…the patents-in-suit. The '667 patent identifies Tris as the assignee of the '667 patent, who	External link to document
2020-11-29	201	Opinion - Memorandum Opinion	in five patents: U.S. Patent Nos. 8,465,765 (the #765 patent), 8,563,033 (the #033 patent), 8,778,390…,390 (the #390 patent), 8,956,649 (the #649 patent), and 9,040,083 (the #083 patent}. Tris Pharma, Inc… #033 patent, claims 6 and 20 of the #765 patent, and claims 15, 16, and 20 of the #390 patent. The Federal… the #033 patent, claim 6 of the #765 patent, and claims 15, 16, and 20 of the #390 patent. Actavis… the #033 patent, claim 6 of the #765 patent, and claims 15, 16, and 20 of the #390 patent are invalid	External link to document
2020-12-03	205	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,465,765 B2; 8,563,033 B1; 8,778,390…2014 4 December 2020 1:14-cv-01309 830 Patent None District Court, D. Delaware	External link to document
2014-10-15	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,465,765 B2; 8,563,033 B1; 8,778,390…2014 4 December 2020 1:14-cv-01309 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.